Software & Fintech, M&A

Bryan, Garnier & Co acts as Sole Financial Advisor to Abenex and the Management of EDL on a secondary LBO led by Dentressangle Capital

Founded in 1994, Edition et Développement Logiciels ("EDL") is a leading software provider for medical imaging services.

With its Xplore software, EDL offers its customers that are both public and private healthcare institutions a fully modern, integrated and SaaS-ready solution which facilitates information sharing and improves the performance of medical imaging departments. Xplore is praised for its ergonomics, its wide set of functionalities and its proven robustness. The solution notably enables an efficient roll-out of tele-radiology within multi-site organisations as well as swift communication flows between radiology departments and the complex medical environment with which it interacts on a daily basis. 

Since 2021, under the joint leadership of the management team and Abenex, EDL has expanded its European footprint by taking a significant market share in Germany and Switzerland. The company has also established itself in Belgium through the acquisition of Thélème, specialised in software dedicated to nuclear medicine, and more recently in Austria.

Bryan, Garnier & Co acts as Sole Financial Advisor to Abenex and the Management of EDL.

Bryan, Garnier & Co organised, prepared and led a limited auction with Tier-1 Private Equity investors. 

Kylian Lopez, the CEO, and the management are also reinvesting heavily alongside Dentressangle Capital to provide EDL with the means to expand its offering and accelerate its development. Additionally, the original founders of EDL have also decided to reinvest in the company, thus demonstrating their renewed confidence in the future of the group. 

This marks another landmark transaction for Bryan, Garnier & Co’s software practice. Other notable transactions include the investment of Francisco Partners in Orisha, the sale of Diapason to PSG Equity, the sale of Sinari to Bridgepoint Development Capital, the investment of Keensight in e-Attestation, the sale of Nomadia to Hg Capital and Carlyle’s investment in Groupe Lacour. 

Following on from Nehs Digital & Xperis, Median Technologies, Evolucare, Padoa, Arche MC2, CBA, Maincare Solutions, BlueBee, Amplexor Life Sciences, Qare, and numerous other landmark transactions in the healthcare technologies sector, this new deal marks another milestone for Bryan, Garnier & Co’s expertise. 

Founded in 1994, Edition et Développement Logiciels (“EDL”) is a leading software provider for medical imaging services. With its Xplore software, EDL offers its customers a fully modern, integrated and SaaS-ready solution which facilitates information sharing and improves the performance of medical imaging departments. Xplore is praised for its ergonomics, its wide set of functionalities and its proven robustness. The solution notably enables an efficient roll-out of tele-radiology within multi-site organisations as well as swift communication flows between radiology departments and the complex medical environment with which it interacts on a daily basis.

Dentressangle is a family-owned investment holding company with net asset value of €3.3 billion. It has two main areas of activity: business investments (long-term majority investments, venture capital via the Hi Inov fund, diversified management with DGO) and real estate (logistics and office properties). The holding company is wholly owned by the Dentressangle family and holds controlling stakes in around 10 companies including equipment rental company Kiloutou, property developer OGIC, digital service provider Tessi, textile personalisation specialist Flexdev, medtech company Acteon and Marle Group, the world’s leading manufacturer of orthopaedic implants and precision instruments. The holding company has more than 70 employees working at its Paris and Lyon offices, as well as locations in Munich and Luxembourg.